BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30132720)

  • 1. Development and Characterization of Monoclonal Antibodies Against Nitro-
    Divya G; Jayaprakash NS; Venkataraman K
    Monoclon Antib Immunodiagn Immunother; 2018 Aug; 37(4):167-174. PubMed ID: 30132720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of anti-chloro
    Lokeshwaran K; Hemadou A; Jayaprakash NS; Prasanna RR; Jacobin-Valat MJ; Dieryck W; Joucla G; Vijayalakshmi MA; Clofent-Sanchez G; Santarelli X; Venkataraman K
    J Immunol Methods; 2019 Nov; 474():112637. PubMed ID: 31386835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Monoclonal Antibody Against Chlorinated 192tyrosine Containing ApoAI Peptide to Screen Quality of Human High Density Lipoprotein (HDL).
    Lokeshwaran K; Venkataraman K
    Protein Pept Lett; 2016; 23(10):905-912. PubMed ID: 27468813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma.
    DiDonato JA; Huang Y; Aulak KS; Even-Or O; Gerstenecker G; Gogonea V; Wu Y; Fox PL; Tang WH; Plow EF; Smith JD; Fisher EA; Hazen SL
    Circulation; 2013 Oct; 128(15):1644-55. PubMed ID: 23969698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to apolipoprotein AI: generation and characterization.
    Falero G; Rodriguez I; Rojas A
    Folia Biol (Praha); 1993; 39(1):14-22. PubMed ID: 7688698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Lab Invest; 2016 Jul; 96(7):708-18. PubMed ID: 27183204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
    Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
    J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An abundant dysfunctional apolipoprotein A1 in human atheroma.
    Huang Y; DiDonato JA; Levison BS; Schmitt D; Li L; Wu Y; Buffa J; Kim T; Gerstenecker GS; Gu X; Kadiyala CS; Wang Z; Culley MK; Hazen JE; Didonato AJ; Fu X; Berisha SZ; Peng D; Nguyen TT; Liang S; Chuang CC; Cho L; Plow EF; Fox PL; Gogonea V; Tang WH; Parks JS; Fisher EA; Smith JD; Hazen SL
    Nat Med; 2014 Feb; 20(2):193-203. PubMed ID: 24464187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to plasma high density lipoprotein (HDL) of eel (Anguilla japonica).
    Ndiaye D; Katoh H; Ge YP; Iijima N; Hayashi S
    Comp Biochem Physiol B Biochem Mol Biol; 2000 Apr; 125(4):473-82. PubMed ID: 10904860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis.
    Vivekanandan-Giri A; Slocum JL; Byun J; Tang C; Sands RL; Gillespie BW; Heinecke JW; Saran R; Kaplan MJ; Pennathur S
    Ann Rheum Dis; 2013 Oct; 72(10):1725-31. PubMed ID: 23313808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody.
    Nakano T; Nagata A
    J Lab Clin Med; 2003 Jun; 141(6):378-84. PubMed ID: 12819635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.
    DiDonato JA; Aulak K; Huang Y; Wagner M; Gerstenecker G; Topbas C; Gogonea V; DiDonato AJ; Tang WHW; Mehl RA; Fox PL; Plow EF; Smith JD; Fisher EA; Hazen SL
    J Biol Chem; 2014 Apr; 289(15):10276-10292. PubMed ID: 24558038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin interactions with apoA1 and SAA in inflammation-associated HDL.
    Digre A; Nan J; Frank M; Li JP
    Biochem Biophys Res Commun; 2016 May; 474(2):309-314. PubMed ID: 27105909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of monoclonal antibodies for the selective isolation of human plasma apolipoprotein A-containing particles.
    Calvo C; Bustos P; Sepulveda J; Ulloa N; Sepulveda V
    Hybridoma; 1995 Dec; 14(6):603-8. PubMed ID: 8770650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice.
    Parastatidis I; Thomson L; Fries DM; Moore RE; Tohyama J; Fu X; Hazen SL; Heijnen HF; Dennehy MK; Liebler DC; Rader DJ; Ischiropoulos H
    Circ Res; 2007 Aug; 101(4):368-76. PubMed ID: 17615369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of superoxide anion attack on the lipoprotein HDL.
    Napolitano G; Fasciolo G; Tomajoli MTM; Carlucci A; Ascione E; Salvatore A
    Mol Cell Biochem; 2023 May; 478(5):1059-1066. PubMed ID: 36219354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function.
    Filou S; Lhomme M; Karavia EA; Kalogeropoulou C; Theodoropoulos V; Zvintzou E; Sakellaropoulos GC; Petropoulou PI; Constantinou C; Kontush A; Kypreos KE
    Biochemistry; 2016 Jul; 55(27):3752-62. PubMed ID: 27332083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I.
    Rothwell TC; Kamanna VS; Jin FY; Koren E; Foley T; Kashyap ML
    Clin Chem; 1995 Aug; 41(8 Pt 1):1150-8. PubMed ID: 7628090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and identification of natural monoclonal antibodies against low-density lipoprotein.
    Feng X; Xu R; Gao Y; He Z; Li C; Wang H
    Hybridoma (Larchmt); 2008 Feb; 27(1):54-8. PubMed ID: 18294078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm.
    Martínez-López D; Camafeita E; Cedó L; Roldan-Montero R; Jorge I; García-Marqués F; Gómez-Serrano M; Bonzon-Kulichenko E; Blanco-Vaca F; Blanco-Colio LM; Michel JB; Escola-Gil JC; Vázquez J; Martin-Ventura JL
    EBioMedicine; 2019 May; 43():43-53. PubMed ID: 30982767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.